| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |